A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(14 sites)

United States

Alabama Clinical Therapeutics, Birmingham, Alabama

Source Healthcare, Santa Monica, California

Vantage Clinical Trials, St. Petersburg, Florida

Vantage Clinical Trials, Tampa, Florida

Injury Care Family Care Research, Boise, Idaho

Axis Spine Center, Post Falls, Idaho

Indiana Spine Group, Carmel, Indiana

The Orthopedic Center of St. Louis, St Louis, Missouri

Wake Research, Wilmington, North Carolina

Carolinas Pain Institute/ Center For Clinical Research, Winston-Salem, North Carolina

Pacific Sports and Spine, Eugene, Oregon

Semmes Murphey Neurological Clinic, Memphis, Tennessee

Pain Specialists of America, Austin, Texas

University of Utah, Salt Lake City, Utah